Play Now Rand - Dollar 16.77 +0.3% Rand - Aus dollar 11.72 +0.2%
In the SURMOUNT-1 clinical trial, individuals with overweight/obesity without diabetes taking tirzepatide (5 mg, 10 mg, and 15 mg once weekly) lost 16%, 21.4%, and 22.5% of body weight, respectively, after 72 weeks
This underscores that tirzepatide is a long term maintenance therapy, not just a short term weight loss tool
Expand Your Laboratory Knowledge Visit Frontier Peptide Labs educational resources to learn more about peptide purity testing, HPLC analysis, LC-MS verification, laboratory handling, storage recommendations, and current areas of peptide research
While it may be tempting to decide to microdose on your own after hearing about all the benefits, it is essential to consult with a medical professional before starting new medications or making changes to your existing medications
Your Centra Internal Medicine team is here to guide and support you in making the best decisions for your long-term health